Treating Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM): Omega-3 Fatty
Acids
Background. Free radicals are imbalanced compounds that
achieve balance by swiping electrons from or giving electrons to other
compounds. Because they typically attack the fatty membranes covering cells free
radicals can wreak havoc on all types of cells. Once damaged these
membranes can emit a variety of substances that further increase free radical
activity.
How it Works. Lipid replacement therapy (LRT) is used
to produce healthy cell membranes that are less susceptible to free radical
attack, to repair membranes quickly once they are damaged, to increase cellular
energy production, and to prevent further free radical activity.
Lipid Replace Therapy May Assist in ME/CFS and FM Because
higher than normal levels of free radical damage (oxidative stress) have been
found in both ME/CFS and fibromyalgia (FM) patients. Recent studies also suggest
ME/CFS patients have high levels of a type of fat (abdominal) that is associated
with high free radical production. LRT could have several benefits in ME/CFS
including:
- Increased Energy Production – Some researchers believe that the
fatigue in chronic illnesses such as ME/CFS and FM occurs when free radicals
Energy
Drugs
Alternative Treatments
Translate this page into any language
inhibit the cells mitochondria from producing energy. Dr. Nicholson used a lipid
replacement product called Propax NT to reduce fatigue, nausea, diarrhea,
insomnia, etc. in cancer and chronically fatigued patients. Two recent studies
found that both mitochondrial function and fatigue were substantially improved
in both moderate and severely chronically fatigued and FM patients.
- Protection From Central Nervous System Infections - Dr. Basant Puri
believes an infection in the central nervous system of ME/CFS patients inhibits
their cells from producing health membranes. He uses an LRT product called 'Eye Q' to provide the
essential fatty acids he believes these viruses are inhibiting.
Eye Q: Dr. Puri used a lipid replacement product called
called 'Eye Q’ in his study. He reported that one ME/ME/CFS patient almost
totally confined to a wheelchair with high fatigue, poor sleep, muscle pain, and
‘low mood’ began to go into remission about six to eight weeks into the program.
At 16 weeks her depression score had dropped from 27 to 3 and she reported that
her sleep was much improved. Her muscle pain, however, was unchanged. Comments
from a group of four ME/CFS patients after 12 weeks of therapy ranged from the
startling ‘the fogginess of the brain was gone completely’ to the hopeful ‘for
the first time a feeling of well being was experienced’ to the more mundane ‘I
am able to communicate during a relapse.’
Dr. Puri also tells a remarkable story of a 20 year old who had become
increasingly suicidal despite using a variety of anti-depressants. One month
after starting 4 g of eicosapentoaenoic acid a day his suicidal thoughts had
disappeared and nine months later all his symptoms had disappeared, his
depression rating, formerly at 32, was zero, and a brain scan indicated that
substantial changes had occurred.
Studies: Despite these successes two prior studies of
LRT therapy in ME/CFS had mixed results. Dr. Maes examination of the lipid
levels in ME/ME/CFS patients indicated that ME/ME/CFS patients had low omega 3/6
ratios and high omega 6 levels relative to healthy controls. This suggested
ME/ME/CFS patients should avoid taking LRT’s containing high omega 6 levels.
The Supplements: Many omega oil supplements are available. The two portrayed in
these studies are:
-
Propax with NT Factor - is portrayed by its
producer, a U.S. based company called Nutritional Therapeutics, as a complete
delivery lipid replacement package. Besides many vitamins and minerals it also
contains amino acids, antioxidants and probiotics. Propax has high omega 3 fatty
acid levels and no omega 6 fatty acids.
- Eye Q - is made by
a U.K. company, Equazen. It contains high levels of omega 3 and low levels of
omega 6 fatty acids (from evening primrose oil) as well as an antioxidant,
vitamin E.
Summary. - While not a cure omega three fatty acids
with low omega six fatty acid levels may benefit some ME/CFS patients.
Fatty acids derived from fish oils should be filtered to ensure no mercury is
present.
(This and all
sections of the Phoenix Rising website are compiled by a layman. They are not a
substitute for a physician and are for informational uses only. Please discuss
any treatments in these pages with your physician.)
_________________________________________
In chronic fatigue syndrome the increased omega-3 polyunsaturated fatty acids
are related to lowered serum zinc and defects in T-cell activation. Maes, M.,
Mahaylova, I. and J. C. Leunis. 2006. Neuroendocrinology Letters 6, 745-751.
Lipid replacement therapy and antioxidant nutritional therapy for restoring
mitochondrial function and reducing the fatigue in chronic fatigue syndrome and
other fatiguing illnesses. Nicholson, G. and R. Ellithorpe. 2006. Journal of
Chronic Fatigue Syndrome 13, 57-58.
Long chain polyunsaturated fatty acids and the path of physiology of myalgic
encephalitis (chronic fatigue syndrome).Puri, B. 2006. Journal of Clinical
Pathology.